Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells

Journal of Nutritional Biochemistry

Volumn 21, Issue 9, 2010, Pages 856-864

  Sakamoto, Takako ^a   Horiguchi, Hyogo ^a   Oguma, Etsuko ^a   Kayama, Fujio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Breast cancer; Cell cycle; Estrogen receptor; Phytoestrogens; Resveratrol

Indexed keywords

COUMESTROL; CYCLIN D1; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENISTEIN; GLYCITEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHYTOESTROGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RESVERATROL;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ESTROGEN RESPONSIVE ELEMENT; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COUMESTROL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; PHYTOESTROGENS; PROTO-ONCOGENE PROTEINS C-BCL-2; STILBENES;

EID: 77955841346     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.06.010     Document Type: Article

References (52)

1. Frasor J., Danes J.M., Komm B., Chang K.C.N., Lyttle C.R., Katzenellenbogen B.S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003, 144:4562-4574.
2. 1-arrested human breast cancer cells. Oncogene 1996, 12:2315-2324.
3. Planas-Silva M.D., Weinberg R.A. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol Cell Biol 1997, 17:4059-4069.
4. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 1997, 272:10882-10894.
5. Liu M.M., Albanese C., Anderson C.M., Hilty K., Webb P., Uht R.M., et al. Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J Biol Chem 2002, 277:24353-24360.
6. Shiozawa T., Miyamoto T., Kashima H., Nakayama K., Nikaido T., Konishi I. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence. Oncogene 2004, 23:8603-8610.
7. Castro-Rivera E., Samudio I., Safe S. Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem 2001, 276:30853-30861.
8. 1 gene transcription in HepG2 cells. Mol Biol Cell 2002, 13:3720-3729.
9. Huang Y., Ray S., Reed J.C., Ibrado A.M., Tang C., Nawabi A., et al. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits Taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res Treat 1997, 42:73-81.
10. Lewandowski S.A., Thiery J., Jalil A., Leclercq G., Szczylik C., Chouaib S. Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity. Oncogene 2005, 24:4789-4798.
11. Rafi M.M., Rosen R.T., Vassil A., Ho C.T., Zhang H., Ghai G., et al. Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res 2000, 20:2653-2658.
12. Leung L.K., Wang T.T.Y. Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7. Breast Cancer Res Treat 1999, 55:73-83.
13. Khaodhiar L., Ricciotti H.A., Li L., Pan W., Schickel M., Zhou J., et al. Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause 2008, 15:125-132.
14. Tice J.A., Ettinger B., Ensrud K., Wallace R., Blackwell T., Cummings S.R. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 2003, 290:207-214.
15. Booth N.L., Piersen C.E., Banuvar S., Geller S.E., Shulman L.P., Farnsworth N.R. Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review. Menopause 2006, 13:251-264.
16. Dai Q., Franke A.A., Jin F., Shu X.O., Hebert J.R., Custer L.J., et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 2002, 11:815-821.
17. Verheus M., van Gils C.H., Keinan-Boker L., Grace P.B., Bingham S.A., Peeters P.H.M. Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 2007, 25:648-655.
18. Iwasaki M., Inoue M., Otani T., Sasazuki S., Kurahashi N., Miura T., et al. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol 2008, 26:1677-1683.
19. Trock B.J., Hilakivi-Clarke L., Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006, 98:459-471.
20. Peeters P.H.M., Keinan-Boker L., van der Schouw Y.T., Grobbee D.E. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat 2003, 77:171-183.
21. Magee P.J., Rowland I.R. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 2004, 91:513-531.
22. Dixon R.A. Phytoestrogens. Annu Rev Plant Biol 2004, 55:225-261.
23. Rice S., Whitehead S.A. Phytoestrogens and breast cancer - promoters or protectors?. Endocr Relat Cancer 2006, 13:995-1015.
24. Hsieh C.Y., Santell R., Haslam S.Z., Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998, 58:3833-3838.
25. Ju Y.H., Allred K.F., Allred C.D., Helferich W.G. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis 2006, 27:1292-1299.
26. Seo H.S., DeNardo D.G., Jacquot Y., Laïos I., Vidal D.S., Zambrana C.R., et al. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 2006, 99:121-134.
27. Ju Y.H., Fultz J., Allred K.F., Doerge D.R., Helferich W.G. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 2006, 27:856-863.
28. Saji S., Okumura N., Eguchi H., Nakashima S., Suzuki A., Toi M., et al. MDM2 enhances the function of estrogen receptor α in human breast cancer cells. Biochem Biophys Res Commun 2001, 281:259-265.
29. Sakamoto T., Eguchi H., Omoto Y., Ayabe T., Mori H., Hayash S. Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells. Mol Cell Endocrinol 2002, 192:93-104.
30. Lehmann L., Esch H.L., Wagner J., Rohnstock L., Metzler M. Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of Daidzein in cultured human Ishikawa cells. Toxicol Lett 2005, 158:72-86.
31. Escande A., Pillon A., Servant N., Cravedi J.P., Larrea F., Muhn P., et al. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol 2006, 71:1459-1469.
32. Harris D.M., Besselink E., Henning S.M., Go V.L.W., Hebe D. Phytoestrogens induce differential estrogen receptor alpha- or beta-mediated responses in transfected breast cancer cells. Exp Biol Med 2005, 230:558-568.
33. Miyashita T., Harigai M., Hanada M., Reed J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994, 54:3131-3135.
34. Catz S.D., Johnson J.L. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer. Oncogene 2001, 20:7342-7351.
35. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299.
36. Bentires-Alj M., Dejardin E., Viatour P., Van Lint C., Froesch B., Reed J.C., et al. Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines. Oncogene 2001, 20:2805-2813.
37. Thompson L.U., Boucher B.A., Liu Z., Cotterchio M., Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 2006, 54:184-201.
38. Clarke D.B., Bailey V., Lloyd A.S. Determination of phytoestrogens in dietary supplements by LC-MS/MS. Food Addit Contam 2008, 25:534-547.
39. Thompson L.U., Boucher B.A., Cotterchio M., Kreiger N., Liu Z. Dietary phytoestrogens, including isoflavones, lignans, and coumestrol, in nonvitamin, nonmineral supplements commonly consumed by women in Canada. Nutr Cancer 2007, 59:176-184.
40. She Q.B., Bode A.M., Ma W.Y., Chen N.Y., Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 2001, 61:1604-1610.
41. Sareen D., Darjatmoko S.R., Albert D.M., Polans A.S. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol 2007, 72:1466-1475.
42. Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafsson J.Å., Kushner P.J., et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 1997, 277:1508-1510.
43. Webb P., Nguyen P., Valentine C., Lopez G.N., Kwok G.R., McInerney E., et al. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 1999, 13:1672-1685.
44. Safe S. Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 2001, 62:231-252.
45. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996, 15:1292-1300.
46. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M., et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 2001, 20:6050-6059.
47. 3-PKC-α signal transduction pathway in HEPG2 cells. Biochem Biophys Res Commun 1998, 245:254-258.
48. Aronica S.M., Kraus W.L., Katzenellenbogen B.S. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 1994, 91:8517-8521.
49. Wu F., Safe S. Differential activation of wild-type estrogen receptor α and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells. J Steroid Biochem Mol Biol 2007, 103:1-9.
50. Perillo B., Sasso A., Abbondanza C., Palumbo G. 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 2000, 20:2890-2901.
51. Dong L., Wang W., Wang F., Stoner M., Reed J.C., Harigai M., et al. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J Biol Chem 1999, 274:32099-32107.
52. Lavigne J.A., Takahashi Y., Chandramouli G.V.R., Liu H., Perkins S.N., Hursting S.D., et al. Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study. Breast Cancer Res Treat 2008, 110:85-98.